Literature DB >> 8415702

A hypothesis for the HLA-B27 immune dysregulation in spondyloarthropathy: contributions from enteric organisms, B27 structure, peptides bound by B27, and convergent evolution.

R H Scofield1, W L Warren, G Koelsch, J B Harley.   

Abstract

Several human rheumatic diseases occur predominantly in persons who carry the histocompatibility (HLA) class I allele B27. They have also been related to Gram-negative enteric microorganisms. In addition, the recent recovery of peptides bound to B27 has allowed an understanding of the structural requirements for their binding. Using the accumulated data base of protein sequences, we have tested a series of hypotheses. First, we have asked whether the primary amino acid sequence of the hypervariable regions of HLA-B27 shares short sequences with the proteins of Gram-negative enteric bacteria. The data demonstrate that, unique among the HLA-B molecules, the hypervariable regions of HLA-B27 unexpectedly share short peptide sequences with proteins from these bacteria. Second, we have asked whether the enteric proteins tend to satisfy the structural requirements for peptide binding to B27 in those regions of the sequence shared with B27. This hypothesis also tends to be true, especially in an allelically variable part of the B27 sequence which is predicted to bind B27 if it were to be presented as a free peptide. We conclude that HLA-B27 and enteric Gram-negative bacteria have undergone a previously unappreciated form of convergent evolution which may be important in the process leading to these rheumatic diseases. Moreover, the regions of the enteric bacterial proteins which are contiguous with the short sequences shared with B27 tend to have structures which are also predicted to bind B27. These observations suggest a mechanism for autoimmunity and lead to the prediction that the B27-associated diseases are mediated by a subset of T-cell receptors, B27, and the peptides bound by B27.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8415702      PMCID: PMC47561          DOI: 10.1073/pnas.90.20.9330

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Antibodies to the peptide from the plasmid-coded Yersinia outer membrane protein (YOP1) in patients with ankylosing spondylitis.

Authors:  N Tsuchiya; G Husby; R C Williams
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

2.  T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis.

Authors:  H Offner; G A Hashim; A A Vandenbark
Journal:  Science       Date:  1991-01-25       Impact factor: 47.728

3.  Identification of an epitope in the major envelope protein of Epstein-Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2).

Authors:  G R Nemerow; R A Houghten; M D Moore; N R Cooper
Journal:  Cell       Date:  1989-02-10       Impact factor: 41.582

4.  Evidence for the translocation of Enterococcus faecalis across the mouse intestinal tract.

Authors:  C L Wells; R P Jechorek; S L Erlandsen
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

5.  Autoantibodies to the HLA-B27 sequence cross-react with the hypothetical peptide from the arthritis-associated Shigella plasmid.

Authors:  N Tsuchiya; G Husby; R C Williams; H Stieglitz; P E Lipsky; R D Inman
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

6.  Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR beta-1 chain and the Epstein-Barr virus glycoprotein gp110.

Authors:  J Roudier; J Petersen; G H Rhodes; J Luka; D A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

7.  Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders.

Authors:  R E Hammer; S D Maika; J A Richardson; J P Tang; J D Taurog
Journal:  Cell       Date:  1990-11-30       Impact factor: 41.582

8.  Relative contributions of host and microbial factors in bacterial translocation.

Authors:  C L Wells; R P Jechorek; K J Gillingham
Journal:  Arch Surg       Date:  1991-02

9.  A Mycobacterium leprae-specific human T cell epitope cross-reactive with an HLA-DR2 peptide.

Authors:  D C Anderson; W C van Schooten; M E Barry; A A Janson; T M Buchanan; R R de Vries
Journal:  Science       Date:  1988-10-14       Impact factor: 47.728

10.  T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP.

Authors:  H S de Koster; D C Anderson; A Termijtelen
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

View more
  27 in total

Review 1.  Anterior uveitis: clinical and research perspectives.

Authors:  J T Rosenbaum; T M Martin; S R Planck
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  [Rheumatology update. Current knowledge of etiology, pathophysiology, diagnosis, and therapy of selected arthritic disorders. Part I: pathogenesis and differential diagnosis].

Authors:  G Hein; P Oelzner; H Sprott; B Manger
Journal:  Med Klin (Munich)       Date:  1999-09-15

Review 3.  HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations.

Authors:  Inés Colmegna; Raquel Cuchacovich; Luis R Espinoza
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

4.  Why HLA-B27? My thirty-year quest: the Friedenwald lecture.

Authors:  James T Rosenbaum
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-29       Impact factor: 4.799

Review 5.  Spondyloarthritis and the microbiome: new insights from an ancient hypothesis.

Authors:  Julia Manasson; Jose U Scher
Journal:  Curr Rheumatol Rep       Date:  2015-02       Impact factor: 4.592

6.  Possible role of HLA-B27 associated cytotoxic T lymphocyte activity in the pathogenesis of the seronegative arthropathies.

Authors:  A F Geczy; J S Sullivan
Journal:  Ann Rheum Dis       Date:  1995-05       Impact factor: 19.103

Review 7.  HLA-B27 and bacteria.

Authors:  J Uksila; P Toivanen
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

Review 8.  Recognition and management of bacterial arthritis.

Authors:  M A Cimmino
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

Review 9.  Ankylosing spondylitis, IgA, and transforming growth factors.

Authors:  J R Archer
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

Review 10.  The role of the gut and microbes in the pathogenesis of spondyloarthritis.

Authors:  Mark Asquith; Dirk Elewaut; Phoebe Lin; James T Rosenbaum
Journal:  Best Pract Res Clin Rheumatol       Date:  2014-11-15       Impact factor: 4.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.